N-(2-aminoethyl)-N-benzyl-1-methyl-1,4-dihydrochromeno[4,3-c]pyrazole-3-carboxamide

ID: ALA4524552

PubChem CID: 155520144

Max Phase: Preclinical

Molecular Formula: C21H22N4O2

Molecular Weight: 362.43

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1nc(C(=O)N(CCN)Cc2ccccc2)c2c1-c1ccccc1OC2

Standard InChI:  InChI=1S/C21H22N4O2/c1-24-20-16-9-5-6-10-18(16)27-14-17(20)19(23-24)21(26)25(12-11-22)13-15-7-3-2-4-8-15/h2-10H,11-14,22H2,1H3

Standard InChI Key:  NPZOLEBIGLVKET-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   18.1763  -13.1659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3477  -12.3486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3466  -13.1682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0546  -13.5771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0529  -11.9398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7615  -12.3450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7603  -13.1657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4665  -13.5747    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.4688  -11.9334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1778  -12.3429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7863  -11.7952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4534  -11.0471    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.6392  -11.1327    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.6002  -11.7915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0120  -12.4973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0056  -11.0819    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.8292  -12.4937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2410  -13.1995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0581  -13.1958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.6066  -13.2069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0184  -13.9128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6109  -14.6177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0220  -15.3231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8401  -15.3199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2453  -14.6053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8318  -13.9029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0925  -10.5253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  7  2  0
  6  5  2  0
  5  2  1  0
  6  7  1  0
  6  9  1  0
  7  8  1  0
  8  1  1  0
  1 10  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  1  0
 11 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 15 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 13 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4524552

    ---

Associated Targets(Human)

NR1H4 Tclin Bile acid receptor FXR (6228 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 362.43Molecular Weight (Monoisotopic): 362.1743AlogP: 2.58#Rotatable Bonds: 5
Polar Surface Area: 73.38Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.15CX LogP: 2.17CX LogD: 0.43
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: -1.04

References

1. Chianelli D, Rucker PV, Roland J, Tully DC, Nelson J, Liu X, Bursulaya B, Hernandez ED, Wu J, Prashad M, Schlama T, Liu Y, Chu A, Schmeits J, Huang DJ, Hill R, Bao D, Zoll J, Kim Y, Groessl T, McNamara P, Liu B, Richmond W, Sancho-Martinez I, Phimister A, Seidel HM, Badman MK, Joseph SB, Laffitte B, Molteni V..  (2020)  Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis.,  63  (8): [PMID:31940200] [10.1021/acs.jmedchem.9b01621]

Source